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ABSTRACT 
Tea (Camellia sinensis) is one of the most popular beverages in Asia. Tea divided into three categories based on degree of 
fermentations, one of them is green tea. Many researchers have reported antioxidant activity of green tea to prevent chronic 
diseases. Daily consumption of green tea can reduce the development of atherosclerotic complication related to stroke, 
myocardial infarction, coronary heart disease, and cardiovascular diseases (CVD). There are evidences from clinical studies that 
prove green tea can play protective role in the development of CVD. Various components of green tea, especially polyphenol, 
have antioxidant and antidyslipidemic activities. The aim of this study was to review the relationship between green tea 
consumption and CVD development. Published randomized controlled trial (RCT) and meta-analysis (2007-2017) were identified 
based on searches of on-line databases (Cochrane Library, PubMed, Science Direct). The search terms used included green tea 
and cardiovascular. From electronic searches database we found 3.642 articles, 6 research articles met inclusion criteria have been 
conducted and summarized. There were significant reduction of total cholesterol (TC) (p<.05) found in 3 articles, low-density 
lipoprotein cholesterol (LDL) found in 4 articles, triglyceride (TG) found in 3 articles, and significant increment of high-density 
lipoprotein (HDL) found in 2 articles. The articles also showed reduction of CVD risk including blood glucose concentration, 
blood pressure, inflammatory biomarker and anthropometrical measurements. Green tea consumption might be associated 
inversely with the development of CVD. The consumption of green tea extract indicates improvement of lipid profile and 
reduction of CVD risk. The utilization of dietary supplement, such as green tea and its polyphenol component, have promising 
potential to prevent the development of CVD complications. 
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Abbreviation : 
ApoA : Apolipoprotein A 
ApoB : Apolipoprotein B 
BMI : Body mass index 
CRP : C-reactive protein 
CVD : Cardiovascular diseases 
DBP : Diastolic blood pressure 
DNA : Deoxyribonucleic acid 
EC : Epicatechin 
EGC : Epigallocatechin 
EGCG : Epigallocatechin-3-0-gallate 
GTE : Green tea extract 
HC : Hip circumference 
HDL : High-density lipoprotein 
LDL : Low-density lipoprotein 
NO : Nitrite oxide 
ROS : Reactive oxygen species 
SBP : Systolic blood pressure 
SOD : Super oxidized dismutase 
TC : Total cholesterol 
TG : Triglyceride 
TNF-α : Tumor necrosis factor-α 
WC : Waist circumference 
I.  INTRODUCTION 
Tea (Camellia sinensis L.; family Theaceae), is the 
most popular beverage and being widely cultivated in 
Asia especially in Southeast Asia[24]. Tea is divided 
into 3 major types based on the processing methods 
which involved the fermentation process. Green tea is 
a type of tea that is not fermented and didn’t go 
through the oxidation process. Fermentation process 
on the tea leaves may reduce the concentration of tea 
catechin. Green tea has the highest cathechin content 
among other types of tea. Those catechin are 
epicatechin (EC), epigallocatechin (EGC) and 
epigallocatechin-3-0-gallate (EGCG) which is the 
largest component of green tea catechins[4]. 
Consumption of green tea or its extract may provide 
protection against chronic diseases, including 
cardiovascular disease (CVD)[7,25]. Tea catechin exert 
variety mechanism of actions that responsible for the 
health benefits of green tea such as antioxidant, anti-
inflammatory, anti-hypertensive, anti-diabetic, anti-
mutagenic, anti-bacterial and anti-viral effect[25]. The 
cardioprotective effect of green tea and EGCG were 
shown in in vivo studies to reduce the development of 
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atherosclerosis and progression of evolving 
atherosclerotic lesion in hypercholesterolemic. Daily 
intake of green tea decreases the incidence of 
coronary heart disease, stroke, and myocardial 
infarction. Green tea has been shown to suppress the 
oxidation of low-density lipoprotein (LDL). It is well 
recognized that LDL is an important risk factor for the 
development of CVD. Supplemented green tea 
catechins in diet or drinking water was shown to 
reduce ApoB, improve the ratio of ApoA-1/ApoB that 
associated with higher risk of CVD, up-regulate LDL 
receptor binding activity and increase the level HDL 
of HDL-cholesterol in vivo[25,21]. 
II. METHOD 
We conducted electronic searches in the following 
databases: Cochrane Library, PubMed and Science 
Direct. Published randomized control trial (RCT) and 
meta-analysis of RCT (2007-2017), the search terms 
used included green tea and cardiovascular. Titles, 
abstracts, and methods were screened for relevance. 
The relevant articles were selected for further 
consideration (Fig. 1).  
A. Search Term and Selection Criteria 
The search term used include: “green tea” and 
“cardiovascular”. These were combined using the 
Boolean logic AND. Studies were eligible for 
inclusion: (1) RCTs and meta-analysis of RCTs 
studies that test the effectiveness of orally 
administered green tea, extract, or isolated polyphenol 
of green tea against placebo, (2) subject that involved 
in this study is healthy subject or those who have high 
risk CVD factors including overweight, obese, 
dyslipidemia, diabetes mellitus and hypertension, (3) 
reported lipid profile (TC, TG, LDL, HDL) and/ or 
SBP, DBP, pulse pressure, glucose metabolism 
indices or inflammatory biomarkers, related to 
metabolic syndrome or all mortality factor relate CVD 
as outcome measures, (4) none of the studies involved 
the subject that presented to be known with CVD 
incident, myocard infarction incident, taking lipid 
lowering agent, cardiovascular intervention including 
percutaneous coronary intervention or coronary artery 
bypass grafting, and restricted to smokers or alcohol 
consumers. 
All article identified from electronic searches were 
screened independently by five investigators (P.A.H., 
F.D.A.Z., F. S., S.A., and A.H.T) based on criteria: 
randomized controlled trial (RCT) or meta-analysis 
article of RCT, year published article 2007-2017 
clinical study. We found 17 articles to be screened for 
the titles, abstracts and methods for relevance. If 
consensus was reached, irrelevant articles were 
excluded and relevant articles were moved to the next 
stage (full-text review). The articles assessed for 
eligibility by inclusion criteria outlined above. In total 
17 articles, only six articles met the inclusion criteria 
and were included in this systematic review. 
B. Data Extraction 
Five reviewers (P.A.H., F.D.A.Z., F. S., S.A., and 
A.H.T) independently extract data using data 
extraction template. The template included the 
following: authors; subject; dose; duration; results; 
study design. 
C. Outcome 
The primary outcomes included in this systematic 
review on the effect of green tea consumption on 
preventing CVD were responses of several biomarkers 
associated with CVD risk factors, including lipid profile 
(TC, TG, LDL, HDL) and/ or SBP, DBP, pulse pressure 
response, glucose metabolism indices, such as fasting 
glucose, fasting insulin levels, and inflammatory 
biomarkers, including C-reactive protein (CRP) and 
Tumor Necrosis Factor-α (TNF-α), and anthropometrical 
measurements including BMI, WC, and HC. 
D. Data Analysis 
Six studies were assessed based on inclusion criteria. 
These studies were analyzed for their design, 
interventions, sample size, and the age and gender of the 
participants, and outcome. P<.05 and P<.001 was 
defined as being statistically significant in this study. 
III. RESULTS 
After literature search through 3 search engines, a total 
of 3642 were identified. Then 3625 articles were 
excluded by tittle screening. Abstracts of the remaining 
17 articles were reviewed and 11 articles were retrieved 
in full text, where did not match inclusion criteria study 
design such as smokers, cardiovascular incident, lipid 
lowering agent patient, and relevant results were not 
reported. These articles were excluded after discussion 
between five independent investigators (Fig. 1). 
As demonstrated in table 1, the studies included here 
were published between the years 2008 and 2015, with 
the numbers of subjects ranging from 46 to 111. Among 
of them, one study was conducted in Japan, two in 
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Poland, one in USA and two in Taiwan. In terms of 
study population, eligible subjects consisted of men and 
women, except for two studies that recruited only 
women[3,11]. The subject of the studies that included to 
the review were three studies recruited obese 
subjects[2,11,20], one trial recruited overweight subjects[3], 
one trial recruited healthy subjects[18] and one trial 
recruited older subjects[17]. Six studies instructed the 
subject to maintain their physical activity and previous 
diet including polyphenol, catechin, or caffeine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Figure 1. Schematic representation of the flow of 
information during the different phases of the systematic 
review 
All studies that included in this systematic review 
showed statistically significant (p<.05) results in 
association between green tea intake and reducing total 
cholesterol and LDL cholesterol[2,3,11,17,18,20], five 
studies showing reduction of triglycerides [2,3,11,17,20] 
and five studies showing protective role of green tea as 
HDL cholesterol enhancement[2,3,11,17,20].  
The metabolic syndrome markers reported in the 6 
studies included systolic blood pressure[2,3,11,18,20], 
diastolic blood pressure[2,3,11,18,20], 
BMI[2,3,11,18,20], WC[2,3,11,17,20], HC[3,11,17], and 
CRP[2]. SBP, DBP, HC, and CRP showed no significant 
difference between baseline characteristic and placebo 
control groups in all studies. Two studies examined the 
effect of 379 mg/day GTE supplementation on 
anthropometric outcome including BMI and waist 
circumference. A study conducted by Bogdanski et al 
(2012), reported that there were no significant in BMI 
and waist circumference after intervention within group 
and between group (p>.05). However, metabolic 
markers, CRP (p<.001), showed improvement within 
and between groups therefore reduce CVD and other 
metabolic syndrome risk[2]. In the other hand, Suliburska 
et al (2012) found the significant reduction on BMI 
(p=.03) and waist circumference (p=.04) on GTE group 
compared to placebo group. 
IV. DISCUSSIONS 
Green tea consumption has been proven to reduce the 
risk of CVD in both people with the risk factors for CVD 
or healthy subjects. The substance that responsible for the 
efficacy produced by green tea is the catechins 
compound, mainly EGCG[5]. Experimental and 
translational clinical studies have provided further insight 
into the mechanisms of benefit for green tea against 
CVD. Those mechanisms are such as anti-oxidant effects, 
anti-inflammatory effects, and improvement of 
endothelial functions[5]. 
A. Anti-oxidant Effect 
All catechin compounds in tea have various biological 
activities with various mechanisms related to their 
chemical structure. EGCG has an antioxidant activity that 
scavenging free radicals in the body[8].Free radicals 
formed from oxidant compounds in the body when the 
body experiencing oxidative stress or inflammation. In 
addition, free radicals also could be formed when the 
body's immune system responds to pathogenic bacteria. 
Free radicals can damage cells, DNA, fat, and protein. 
Research that conducted by Guo et al (1999) and 
Sutherland (2006) reported that EGCG can scavenge 
superoxide compounds and hydroxyl radicals comprising 
1,1-diphenyl-3-Picrilhidrazil, ROS (Reactive Oxygen 
Species), radical peroxyl, nitrite oxide (NO), radical Free 
carbon-center, oxygen singlet and free radical lipids, and 
peroxynitrite with the nitration barrier of tyrosine. 
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Figure 2. Autooxidation EGCG mechanism of action[10] 
Mechanism of action of EGCG as free radical scavenger 
is due to the one electron reduction potential. 
Antioxidant activity as hydrogen or electron donor is 
determined by this reduction potential of free radicals. 
Hou et al (2005) reported that EGCG was auto-oxidized 
under cell culture conditions. The reaction probably 
catalyzed by metal ions such as Cu2+ in the culture 
medium, produces superoxide radicals and EGCG 
radicals (EGCG). The superoxide radical can further 
react with another EGCG molecule to produce H2O2 and 
EGCG. Two EGCG molecules may collide to form a 
dimer. It is more likely, however, for the EGCG to 
attack the hydroxyl group of another EGCG molecule, 
which is more abundant, to form a dimer radical (dimer). 
The dimer radical can react with molecular oxygen to 
form the EGCG dimer and regenerate the superoxide 
radical. An alternative mechanism is that the EGCG is 
oxidized by molecular oxygen to form O2 and EGCG 
quinone, and the quinone will react with another 
molecule of EGCG to form the dimer. In either case, the 
reaction is propagated by the reaction of superoxide with 
EGCG, generating EGCG dimers and H2O2. Dimers can 
be further transformed to other compound, presumably 
polymer, in a similar manner of oxidation. The addition 
of Super Oxidized Dismutase (SOD) facilitates the 
conversion of O2 to H2O2 and inhibits the propagation of 
the chain reactions. Therefore, the auto-oxidation of 
EGCG is inhibited. More researches is needed to 
substantiate these mechanisms[10]. 
 
 Table 1. Characteristics of enrolled clinical trials and study design 
 
Authors Subjects Dose Duration Results Study Design 
Bogdanski et al., 
2012 
Obese adults; n = 56; 
20-60 years 
379 mg GTE(208 mg 
of EGCG)/ day 
3 month ↓TC, LDL,TG, ↑HDL 
(significant different 
between groups) 
Randomized double-blind, 
placebo-controlled trial 
Suliburska et al., 
2012 
Obese adults; n = 46; 
30-60 years 
379 mg GTE(208 mg 
of EGCG)/ day 
3 month ↓TC, LDL, TG 
(significant different 
between groups) 
↑HDL (no significant 
different between 
groups) 
Randomized, double-blind, 
placebo-controlled 
 
Miyazaki R. et al., 
2013 
Older adults; n = 52 630,9 GTC/ day 14 months ↓TC, LDL (significant 
different within group) 
↓TG, ↑HDL (no 
significant different 
within group) 
A randomized controlled trial 
using a double-blind, placebo-
controlled design 
Nantz, Meri P., 
2008 
Healthy adults; n = 111; 21-
70 years 
200 mg GTC/ daily 3 weeks ↓TC, LDL (significant 
different within group) 
A randomized, double-blind, 
placebo-controlled parallel 
study. 
Hsu et al., 2008 Obese subjects; n = 100; 16-
60 years 
400mg GTE/ daily 12 weeks ↓LDL, TG, ↑HDL 
(significant different 
between group) 
A randomized, double-blind, 
placebo-controlled clinical trial. 
Chen et al., 2015 Overweight adults; n = 92; 
20-60 years 
500mg GTE(285,6 mg 
EGCG)/ daily 
12 weeks ↓TC, LDL (significant 
different between group) 
↓TG, ↑HDL (no 
significant different 
between group) 
-A randomized, double-blind, 
placebo-controlled clinical trial 
 
Abbreviation: HDL=High-density lipoprotein; LDL= Low-density lipoprotein; TC= Total cholesterol; TG= Triglyceride 
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B. Anti-inflammation Effect 
Inflammation is one of the processes that involved in 
the earliest stage of atherogenesis to later stage of plaque 
formation and rupture which causes clinical events such 
as myocardial infarction and stroke[13].  In vitro studies 
have proven the effects of green tea catechin towards 
inflammatory cells. Leukocyte has the important role in 
the inflammation process, it migrates from the 
intravascular space into the tissues to attack micro-
organisms and EGCG have found to be a potent inhibitor 
of leukocyte migration through endothelial cell 
monolayer[9]. Besides leukocyte neutrophils also play an 
essential role in host defense and inflammation. EGCG 
has strong effects in inhibiting the neutrophil elastase. 
Both oral EGCG and GTE block neutrophil-mediated 
angiogenesis in vivo in an inflammatory angiogenesis 
model[6]. Green tea catechins have been shown in 
inhibiting the cytokine-induced adhesion molecule 
expression and monocyte adhesion in cultured 
endothelial cells[16]. 
C. Improvement of Endothelial Function 
The endothelium is a major regulator of vascular 
homeostasis and controls arterial tone, thrombosis, the 
composition of the arterial wall, and local inflammation 
by production of a variety of factors, including nitric 
oxide nitric oxide[23]. Recent studies indicate that green 
tea extracts and individual GTC, including EGCG 
stimulate phosphorylation of endothelial nitric oxide 
synthase (eNOS) at serine 1177, a response that 
increases production of nitric oxide[1,14,15]. In in vitro 
studies, Caveolin-1 (Cav-1), a negative regulator of 
eNOS, was down regulated by green tea 
polyphenols[17]. Experimental studies provide strong 
evidence that green tea acts via specific signaling 
pathways in endothelial cells that are relevant to the 
pathogenesis of atherosclerosis. It shows the strong links 
between endothelial dysfunction and the pathogenesis of 
atherosclerosis. Therefore, this mechanism might 
account for reducing the cardiovascular risk among 
individuals with higher green tea consumptions[5]. 
Several limitations of studies such as uncontrolled 
diet and physical activity, time consumption of green 
tea, inadequate of sample-size and short-terms study 
may cause bias of the study and clinical effect 
association. However, none of the studies were 
sponsored by pharmaceutical companies and were not 
indicated any conflict of interest. Further meta-analysis 
assessing the summary effects of green tea was 
precluded because of study heterogeneity caused by the 
dosage and duration of green tea consumption, varied 
condition outcomes, different P-value that defined as 
statistically significant outcomes and so on. 
V. CONCLUSION 
The consumption of green tea extract improved lipid 
profile such as LDL, TC, TG, and HDL and therefore 
potentially reduce CVD development. 
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